Neuropace Inc (NPCE) is lower by Wednesday morning, with the stock losing -5.05% in pre-market trading to 8.46. NPCE's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. In the Medical Devices industry, which ranks 117 out of 146 industries, Neuropace Inc ranks higher than 100% of stocks. Neuropace Inc has risen 117.85% over the past month, closing at $4.20 on August 2. During this period of time, the stock fell as low as $4.10 and as high as $7.16. NPCE has an average analyst recommendation of Strong Buy. The company has an average price target of $7.33.
NPCE has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on NPCE!